What effect did beta-blockers have on mortality and hospitalization in CKD patients?
Beta-blockers had a clinically important reduction in deaths for CKD class 3a (n=1645) and CKD class 3b-4 (n=958). There was also a clinically important reduction in HF hospitalizations for both CKD class 3a (n=669) and CKD class 3b-4 (n=450) with beta-blockers.